Colchicine compared with placebo for moderate aortic valve stenosis
Tests whether colchicine slows moderate aortic valve stenosis, compared with placebo.
Key facts
- Who runs it
- Stichting Radboud universitair medisch centrum
- Where
- Alkmaar and Nijmegen, NetherlandsSee the 2 sites
- Registry title
- Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 150 people, planned
- Started
- 6 Dec 2024
- Planned end
- 22 Dec 2025
- Type of study
- Interventional
- Record updated
- 3 June 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with moderate narrowing of the aortic heart valve (aortic valve stenosis) who have no symptoms. It compares colchicine with a placebo (dummy pill).
- Age
- 50 to 80 years (people under 50 or over 80 cannot join)
- Sex
- All sexes
- Disease stage
- Moderate aortic valve stenosis without symptoms, seen on a heart ultrasound (echocardiography) from the last 6 months.
- Earlier treatment
- People cannot join if they use CYP3A4 or P-glycoprotein inhibitors (e.g. verapamil), bisphosphonate or denosumab. Long-term use of immunosuppressants or anti-inflammatory drugs, including colchicine and NSAID's, also rules people out. Acetylsalicylic acid is allowed.
Main reasons for not taking part
- Heavily calcified aortic valve (grade 4), bicuspid or rheumatic aortic valve, or valve disease from past chest radiation
- Aortic valve replacement planned in the next six months, or life expectancy under 2 years
- Severe mitral valve stenosis (MVA < 1cm2), severe mitral or aortic valve leakage, or LVEF < 35%
- Pacemaker or internal cardiac defibrillator, active or chronic liver disease, or eGFR <30 ml/min/1.73 m2
- Long-term stomach or bowel complaints, or able to become pregnant without using contraception
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Asymptomatic moderate aortic valve stenosis on recent (<6 months) echocardiography (based on aortic valve peak velocity, aortic valve mean pressure gradient, aortic valve area). The severity of AS will be quantified according to current EACVI / ASE guidelines
Who cannot take part
- Use of CYP3A4 (e.g. verapamil) or P-glycoprotein inhibitors
- Chronic use of immunosuppressants or anti-inflammatory drugs including colchicine and NSAID's (excl. acetylsalicylic acid)
- Active or chronic liver disease
- The presence of a pacemaker or internal cardiac defibrillator
- Rheumatic aortic valve disease
- Valvular disease due to history of chest radiation
- Left ventricular dysfunction (LVEF < 35%)
- Renal impairment (eGFR <30 ml/min/1.73 m2)
- Patients aged <50 and >80 years
- Life expectancy <2 years
- Heavily calcified aortic valve on echocardiography (defined as grade 4 calcification: extensive thickening/calcification of all cusps as described in the articles by Rosenhek et al.)
- Pre-existing chronic gastro-intestinal complaints which may obscure signs of colchicine intolerance
- Child-bearing potential without the use of contraception
- Use of bisphosphonate or denosumab
- A planned aortic valve replacement in the next six months
- Severe mitral valve stenosis (MVA < 1cm2)
- Severe mitral or aortic valve regurgitation
- Bicuspid aortic valve
Where in Netherlands
- Noordwest Ziekenhuisgroep StichtingAlkmaar, NetherlandsTaking people
- Radboud universitair medisch centrum StichtingNijmegen, NetherlandsTaking people
About the trial
What the trial wants to find out
To study the effect of colchicine treatment versus placebo on the progression of aortic valve stenosis in patients with moderate aortic valve stenosis.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Does Colchicine Reduce Progression of Aortic Valve Stenosis? Colchicine and Inflammation in Aortic Stenosis (CHIANTI): A placebo-controlled, double-blind, multicenter randomized trial.
- Plain-language title
- Colchicine compared with placebo for moderate aortic valve stenosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 3 June 2025